BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35768646)

  • 1. Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.
    Zhao Y; Huang X; Zhu D; Wei M; Luo J; Yu S; Tian Y; Zheng X
    Cell Death Differ; 2022 Dec; 29(12):2531-2544. PubMed ID: 35768646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
    Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
    Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR.
    Fu X; Zhao J; Yu G; Zhang X; Sun J; Li L; Yin J; Niu Y; Ren S; Zhu Y; Xu B; Huang L
    Commun Biol; 2022 Mar; 5(1):182. PubMed ID: 35233061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission.
    Shi L; Liu J; Peng Y; Zhang J; Dai X; Zhang S; Wang Y; Liu J; Long J
    Mol Oncol; 2020 Dec; 14(12):3169-3183. PubMed ID: 33070427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian tumor deubiquitinase 6A regulates cell proliferation via deubiquitination of nucleolin and caspase‑7.
    Kim SH; Baek KH
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36082810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Deubiquitinase USP38 Promotes NHEJ Repair through Regulation of HDAC1 Activity and Regulates Cancer Cell Response to Genotoxic Insults.
    Yang Y; Yang C; Li T; Yu S; Gan T; Hu J; Cui J; Zheng X
    Cancer Res; 2020 Feb; 80(4):719-731. PubMed ID: 31874856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP13 regulates the replication stress response by deubiquitinating TopBP1.
    Kim W; Zhao F; Gao H; Qin S; Hou J; Deng M; Kloeber JA; Huang J; Zhou Q; Guo G; Gao M; Zeng X; Zhu S; Tu X; Wu Z; Zhang Y; Yin P; Kaufmann SH; Luo K; Lou Z
    DNA Repair (Amst); 2021 Apr; 100():103063. PubMed ID: 33592542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinase OTUD6a drives cardiac inflammation and hypertrophy by deubiquitination of STING.
    Fang Z; Han J; Lin L; Ye B; Qu X; Zhang Y; Zhao Y; Xu D; Lin W; Shen S; Min J; Wu G; Huang Z; Liang G
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167061. PubMed ID: 38342418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.
    Kim HJ; Kim J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deubiquitinase OTUD6A Regulates Innate Immune Response via Targeting UBC13.
    Li Z; Li G; Li Y; Luo Y; Jiang Y; Zhang Z; Zhou Z; Liu S; Wu C; You F
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.
    Liu K; Graves JD; Lin FT; Lin WC
    J Biol Chem; 2021; 296():100382. PubMed ID: 33556369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3.
    Sun X; Chen S; Zhao Y; Wu T; Zhao Z; Luo W; Han J; Fang Z; Ye B; Cao G; Huang S; Liang G
    Am J Physiol Cell Physiol; 2024 Feb; 326(2):C400-C413. PubMed ID: 38105755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc.
    Peng Y; Liu J; Wang Z; Cui C; Zhang T; Zhang S; Gao P; Hou Z; Liu H; Guo J; Zhang J; Wen Y; Wei W; Zhang L; Liu J; Long J
    Cell Death Differ; 2022 Sep; 29(9):1730-1743. PubMed ID: 35217790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics.
    Ma S; Zhang J; Guo Q; Cao C; Bao K; Liu L; Chen CD; Liu Z; Yang J; Yang N; Yao Z; Shi L
    Cancer Lett; 2022 Apr; 530():29-44. PubMed ID: 35051531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human TopBP1 ensures genome integrity during normal S phase.
    Kim JE; McAvoy SA; Smith DI; Chen J
    Mol Cell Biol; 2005 Dec; 25(24):10907-15. PubMed ID: 16314514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.
    Laine A; Nagelli SG; Farrington C; Butt U; Cvrljevic AN; Vainonen JP; Feringa FM; Grönroos TJ; Gautam P; Khan S; Sihto H; Qiao X; Pavic K; Connolly DC; Kronqvist P; Elo LL; Maurer J; Wennerberg K; Medema RH; Joensuu H; Peuhu E; de Visser K; Narla G; Westermarck J
    Cancer Res; 2021 Aug; 81(16):4319-4331. PubMed ID: 34145035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between Rad9-Hus1-Rad1 and TopBP1 activates ATR-ATRIP and promotes TopBP1 recruitment to sites of UV-damage.
    Ohashi E; Takeishi Y; Ueda S; Tsurimoto T
    DNA Repair (Amst); 2014 Sep; 21():1-11. PubMed ID: 25091155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claspin operates downstream of TopBP1 to direct ATR signaling towards Chk1 activation.
    Liu S; Bekker-Jensen S; Mailand N; Lukas C; Bartek J; Lukas J
    Mol Cell Biol; 2006 Aug; 26(16):6056-64. PubMed ID: 16880517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importin β-dependent nuclear import of TopBP1 in ATR-Chk1 checkpoint in Xenopus egg extracts.
    Bai L; Michael WM; Yan S
    Cell Signal; 2014 May; 26(5):857-67. PubMed ID: 24440306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication.
    Feng H; Lu J; Song X; Thongkum A; Zhang F; Lou L; Reizes O; Almasan A; Gong Z
    Nucleic Acids Res; 2020 Nov; 48(19):10940-10952. PubMed ID: 33010150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.